When it comes to regulating CBD, the FDA has prioritized pharmaceutical monopoly over public health, leaving the consuming public and honest brands to fend for themselves. And with its recent rejection of “full spectrum” New Dietary Ingredient Notifications, the Agency has only pushed its head further into the sand. Join Justin Singer, CEO & Co-Founder of Caliper Foods, for this complimentary webinar, where he’ll review how we got here, and what’s next for a category that’s waiting—and waiting—for responsible unlock.

Dont miss out - register today!